Previous 10 |
home / stock / chgcy / chgcy news
Shares of Verastem Oncology (NASDAQ: VSTM) , a biotechnology company developing new cancer drugs, are on the rise again after the company announced an upcoming conference call. Investors excited to hear what management will have to say about an investigator-initiated study (i.e., on...
Drivers of the multi-year underperformance US Healthcare is the 2nd largest equity sector, with a 14% index weight , and has been a perennial underperformer the last five years (see chart), and lagged by 10 points last year alone. This was even as the sector has continued to post robust g...
Introduction - good things may be happening here I stopped trading or commenting on Alexion ( ALXN ) in the first half of 2017, when there were countless uncertainties. ALXN was around $110 and was sold at a small loss. ALXN closed Wednesday at $125.18, lagging the market ( SPY ) and a major...
The FDA designates Chugai Pharmaceutical's ( OTCPK:CHGCY ) Phase 3-stage satralizumab, an IL-6 receptor humanized recycling antibody, a Breakthrough Therapy for the treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders (NMO/NMOSD), autoimmune dysfunctions primaril...
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q2 earnings Read more ...
This article is the second of two parts discussing Alexion Pharmaceuticals ( ALXN ) and its competition. Make sure to check out Part 1 here if you have not already. In Part 2 I will focus mostly on ALXN’s competition. I have previously reviewed a large number of ALXN’s compet...
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...
Industry Developments James Watson, who co-discovered the double-helix structure of DNA in 1953, will lead a new international life science research center in the International Bio Valley, located in Shenzhen's Dapeng New Area. A groundbreaking ceremony was held last Friday with Dr. Watson i...
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2017 Q4 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
Chugai Pharmaceuticals Co. Ltd. ADR Company Name:
CHGCY Stock Symbol:
OTCMKTS Market:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...
Grandsouth Bancorporation (GRRB) is expected to report for quarter end 2023-09-30 Cadence Bank (CADE) is expected to report $0.56 for Q3 2023 Enterprise Financial Services Corporation (EFSC) is expected to report $1.24 for Q3 2023 Blackhawk Bancorp Inc. (BHWB) is expected to report fo...